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Objective To determine the frequency of presentations and infectious-disease burden at primary health care (PHC) services in young 
children in two remote Aboriginal communities in tropical northern Australia.
Methods Children born after 1 January 2001, who were resident at 30 September 2005 and for whom consent was obtained, were 
studied. Clinic records were reviewed for all presentations between 1 January 2002 and 30 September 2005. Data collected included 
reason for presentation (if infectious), antibiotic prescription and referral to hospital.
Findings There were 7273 clinic presentations for 174 children aged 0–4.75 years, 55% of whom were male. The median 
presentation rate per child per year was 16 (23 in the first year of life). Upper-respiratory-tract infections (32%) and skin infections 
(18%) were the most common infectious reasons for presentation. First presentations for scabies and skin sores peaked at the age   
of 2 months. By 1 year of age, 63% and 69% of children had presented with scabies and skin sores, respectively.
Conclusion These Aboriginal children average about two visits per month to PHC centres during their first year of life. This high rate 
is testament to the disease burden, the willingness of Aboriginal people to use health services and the high workload experienced by 
these health services. Scabies and skin sores remain significant health problems, with this study describing a previously undocumented 
burden of these conditions commencing within the first few months of life. Appropriate prevention and treatment strategies should 
encompass early infancy to reduce the high burden of infectious diseases in this population.
Bulletin of the World Health Organization 2008;86:275–281.
Une traduction en français de ce résumé figure à la fin de l’article.  Al final del artículo se facilita una traducción al español.
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Introduction
There is a disproportionate disease bur-
den in remote Aboriginal communities 
compared with the general Australian 
population.1–5 These discrepancies be-
gin at birth: the perinatal mortality 
rate for Aboriginal infants in Darwin is 
three times that of the non-indigenous 
population.6 Health problems in these 
communities are similar to those seen 
in developing-country contexts.1,7–9 
Indigenous children suffer from a wide 
variety of diseases including some   
rarely, if ever, seen in the non-indige-
nous population since improvements 
in economic and living conditions led 
to a reduction in the burden of infec-
tious diseases.1
Primary health care (PHC) centres, 
including both Aboriginal-community 
controlled health services and govern-
ment-run clinics, are present in most 
remote communities in Australia. Staff 
numbers vary but usually include a 
nurse clinic manager and Aboriginal 
health workers. Additional clinical nurs-
ing staff members vary depending on 
the size of the PHC centre and are 
supported by either resident or visiting 
medical officers. Skin infections and in-
festations are among the most common 
reasons for children in these communi-
ties to present to PHC centres.10 These 
conditions remain a significant public-
health problem in developing countries 
and among indigenous populations in 
industrialized nations. In resource-poor 
communities worldwide, scabies preva-
lence in the general population is up to 
10%.11 In remote Aboriginal commu-
nities in Australia’s Northern Territory, 
scabies is endemic, with up to 50% of 
children and 25% of adults infested at 
some times.12,13
Secondary infection of scabies 
lesions is common. Group A strepto-
coccal pyoderma is very common in 
Aboriginal children in the Northern 
Territory,14,15 with 50–70% of cases 
reported to be secondary to scabies.12,13 
Group  A  streptococcal  pyoderma   
leads  to  acute  poststreptococcal 
glomerulonephritis,16,17 and underlies 
most cases of invasive group A strepto-
coccal infections, especially in tropical 
regions.18,19 Links between scabies and 
high rates of acute rheumatic fever in 
remote Aboriginal communities in the 
Northern Territory have also been pos-
tulated.20 With rates of poststreptococ-
cal disease in these communities being 
among the highest in the world,21,22 
prevention of scabies and skin sores 
in this region could have far-reaching 
implications.
We aimed to review clinic presenta-
tions in the first few years of life within 
two remote Aboriginal communities of 
Australia to assess the level of health-
care seeking behaviour in this context 
and to determine the burden of scabies,   
skin sores and other infectious diseases.276 Bulletin of the World Health Organization | April 2008, 86 (4)
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Methods
A retrospective review of clinic records 
was done in two PHC centres in the 
remote East Arnhem region of the 
Northern Territory, Australia. These were 
two of six communities participating 
in the East Arnhem Regional Healthy 
Skin Project, a regional collaboration 
to reduce the prevalence of scabies, skin 
sores and associated chronic diseases in 
the participating communities, located 
about 500 km east of Darwin.
The two communities included in 
the medical-record review each had a 
population of about 800 people. The 
clinics are the only PHC centres in the 
communities. For the purposes of the 
review, the study population comprised 
all children born after 1 January 2001, 
who were resident in the two communi-
ties as of 28 September 2005, for whom 
we had consent to review their health 
records (age range 0–4.75 years).
Ethics approval was obtained from 
The Human Research Ethics Committee 
of the Northern Territory Department of 
Health and Community Services and 
Menzies School of Health Research.
The record review was undertaken 
during October and November 2005. 
Data were collected for all presentations 
recorded in the child’s clinic file during a 
period of 3 years and 9 months (1 January 
2002 to 30 September 2005).
Data collected were: the date of 
each presentation, the child’s height 
and weight, any infectious reason for 
presentation, antibiotic prescription   
and any referral to hospital. Recorded 
reasons for presentation and classifica-
tions used were the following: scabies 
(either noted specifically or with refer-
ence to scabies treatment given); skin 
sores (any mention of skin sores or 
other presumed bacterial infections of 
the skin including boils, carbuncles, 
abscesses, ulcers and pustules); tinea 
(tinea, ringworm, fungal skin infection 
or treatment with tinea medication); 
ear disease (mention of any middle-
ear infection or symptoms of such an 
infection, including acute and chronic 
suppurative otitis media or otitis media 
with effusion); throat infection (throat 
or tonsils red, pink, sore, inflamed or 
infected or the presence of pharyngitis 
or laryngitis); acute poststreptococcal 
glomerulonephritis; acute rheumatic 
fever (probable or confirmed diagnosis); 
lower-respiratory-tract infection (pres-
ence of pneumonia, bronchitis, bron-
chiolitis, chest infection or crackles or 
a combination of symptoms suggestive 
of these conditions); upper-respiratory-
tract infection (any mention of an 
upper-respiratory-tract infection, cold 
or flu or symptoms of an infection in-
cluding cough, runny nose or blocked 
nose, but not including sore throat 
in the absence of other symptoms); 
diarrhoea (diarrhoea or fluid, loose or 
watery bowel motions recorded); and 
other febrile illness (temperature of   
> 37.5 °C or the child noted to be 
febrile with no temperature recorded). 
Multiple reasons could be recorded for 
each presentation.
Multiple presentations on the same 
day were recorded as the one presenta-
tion. Presentations with missing or 
incomplete dates were excluded.
Data were analysed in Stata version 
9.1.23 Data were examined per child or 
per presentation. Continuous skewed 
data were expressed as medians (inter-
quartile range) and dichotomous data 
as percentages. Median presentations 
in the first and fourth years of life are 
reported for children for whom data was 
collected for that entire year of life. Di-
chotomous data were compared by use 
of two methods: relative risk with 95% 
confidence intervals (CI); and general-
ized estimating equations.
Results
There were 198 children in the study 
population. Clinic records were re-
viewed for 174 children (80%). In total, 
there were 7273 presentation records 
reviewed for these 174 children. The   
date was incomplete or missing for a 
further 75 presentations, which were 
excluded from the study. Due to the na-
ture of the study, and the study period 
used, children were followed for vary-
ing lengths of time. Data were collected 
from birth for 126 children, and for the 
entire first year of life for 114 children 
(the remaining 12 children were aged   
< 1 year at the time of the record re-
view). The study population was 55% 
male.
There was a median of 16 (inter-
quartile range, IQR: 10–22) presenta-
tions per child per year over the study 
period. During the first year of life, the 
median number of presentations per 
child was 23 (IQR: 13.5–30). In con-
trast, older children presented less fre-
quently, with those aged 3 years having 
Table 1.  Reasons for presentation of children at two remote community health clinics, 
East Arnhemland, January 2002 to September 2005
a
Reasons for 
presentation
Number of 
presentations
b
Number of children 
presenting
b
Median of 
presentations
c
Non-infectious cause   2494   (34.3)   173   (99.4)   8   (5–11)
Upper respiratory tract 
infections (URTI)
  2313   (31.8)   172   (98.9)   7.5   (4–11)
Scabies and/or skin sores   1328   (18.3)   160   (91.9)   4   (2–6)
Scabies   569   (7.8)   131   (75.3)   3   (1–4)
Skin sores   1081   (14.9)   154   (88.5)   2   (1–5)
Ear disease   1288   (17.7)   159   (91.4)   3   (1–6)
Febrile illness   1082   (14.9)   160   (92.0)   3   (1–4)
Diarrhoea   1021   (14.0)   153   (87.9)   3   (1–6)
Lower respiratory tract 
infections (LRTI)
  779   (10.7)   139   (79.9)   2.5   (1–5)
Throat infection   206   (2.8)   91   (52.3)   1   (1–2)
Tinea   184   (2.5)   83   (47.7)   1   (1–2)
Acute poststreptococcal 
glomerulonephritis
  6   (0.1)   2   (0.0) –
Acute rheumatic fever   1   (0.0)   1   (0.0) –
Total presentations   7273   (100)   174   (100)   23   (13.5–30)
a  Total presentations = 7273, total of cause = 12 484, as more than one reason may be recorded per visit. 
Data were analysed using Stata version 9.1.23
b  Percentage presented in parentheses.
c  Median number of presentations in the first year of life among those children who did present and for 
whom data is available for entire first year; interquartile range presented in parentheses.Research
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Fig. 1. Presentations for scabies in two remote communities in East Arnhemland, 
January 2002 to September 2005
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a  Data were analysed in Stata version 9.1.23
a median of 5 (IQR: 3–9) presentations   
per child. At least one infectious con-
dition was reported for two-thirds 
(65.7%) of presentations, with a median 
of 2 (IQR: 1–2) infection-related prob-
lems per presentation and up to 6 at a 
single consultation.
Upper-respiratory-tract infection 
was the most common reason for pre-
sentation among those specifically 
monitored, noted in 32% of presenta-
tions, and seen at least once in 172 
(99%) children. The number of pre-
sentations for upper-respiratory-tract 
infections was almost equal to that for 
all non-infectious reasons (34%). Skin 
sores, scabies or both were the next 
most common reason for presentation, 
seen at 18% of presentations. Of the 
174 children, 160 (92%) had at least 
one presentation over the study period 
with skin sores or scabies. The median 
number of presentations in the first 
year of life was 3 (IQR: 1–4) for scabies 
and 2 (IQR: 1–5) for skin sores. Other 
common reasons for presentation to 
the PHC centre were ear disease, febrile 
illness, diarrhoea and lower-respiratory-
tract infection (Table 1).
Scabies was recorded in a higher 
proportion of presentations in children 
aged < 1 year than in those aged 1–4 
years (8.8% versus 6.8%, P = 0.007), 
whereas skin sores were more common 
in the older age group (10.5% among 
those aged < 1 year compared with 
19.0% among those aged 1–4 years,   
P < 0.001). Children aged < 1  year 
Fig. 2. Presentations for skin sores in two remote communities in East Arnhemland, 
January 2002 to September 2005
a
a  Data were analysed in Stata version 9.1.23
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who had scabies were 6.9 (95% CI: 
5.8–8.2) times more likely to have 
skin sores at that presentation than 
those without scabies. Having scabies 
increased the risk of skin sores by 4.4 
(95% CI: 3.9–4.9) times in children 
aged 1–4 years.
Of the 126 children for whom 
data were collected from birth, 92   
(73%) and 108 (86%) presented at 
least once with scabies and skin sores, 
respectively. All of these children had 
presented for the first time with sca-
bies and skin sores before they reached 
2 years, with the exception of one child 
whose first presentation with skin sores 
was at age 31 months. By the age of 
1 year, 63% and 69% of all children (and   
87% and 81% of those ever seen with 
the conditions) had presented with 
scabies and skin sores, respectively. A 
large peak in first presentations for both 
scabies and skin sores occurred at the 
age of 2 months (Fig. 1 and Fig. 2).
Discussion
Access to primary health care is a criti-
cal component of a healthy start to life. 
However, Aboriginal children born into 
the two communities reviewed in our 
study spend substantial time in clinics 
in the first year of life. Some of these 
visits would be for well-baby checks, 
but with 50% of infants presenting 23 
times or more in the first year of life – 
about twice each month – the disease 
burden is clearly very high. The high 
frequency of presentation for medical   
care is also a testament to the willingness 
of Aboriginal people to use health ser-
vices and the high workload experienced 
by these health services. Others have 
shown that Aboriginal health services in 
other parts of the country are similarly 
faced with high work loads and complex 
health-care needs, with more problems 
being dealt with per consultation than 
in Australian general practice.24,25
Our study represents only those 
cases presenting for medical care, we 
did not review the records for 20% of 
the target population and were there-
fore unable to determine the disease 278 Bulletin of the World Health Organization | April 2008, 86 (4)
Research
Disease burden in Aboriginal communities Danielle B Clucas et al.
burden among this group. Absence 
from the clinic does not mean absence 
of disease, and the true burden of dis-
ease may well be even higher. Given 
the extraordinarily high rates of clinic 
presentations among the study group, 
illness in childhood becomes the norm, 
and many more instances of ill health 
probably remain undiagnosed.
Although our study shows that 
children use the health services, ac-
cess to specialist care is very limited. 
Aboriginal health workers make up 
65% of health professionals working 
in the community-controlled sector, 
but often a lower proportion in govern-
ment clinics.26 Very young children are 
accessing medical care more, and these 
barriers and weaknesses will therefore 
have a disproportionate impact on this 
vulnerable group.
We describe a very high burden of 
disease due to respiratory-tract infec-
tions, scabies and skin sores at a very 
young age, clearly demonstrating that 
skin infections or infestations are almost 
universal in young Aboriginal children, 
and one of the most common reasons 
for children to present to clinics in these 
communities.
Respiratory-tract infections are a 
prominent cause of hospitalizations 
among young Aboriginal children,27,28 
and this study indicates that they also 
represent most of the infectious-disease 
burden at the PHC level. In order to 
ensure that hospitalization (necessitat-
ing removal of the child from their 
community) is minimized, there is a 
need for adequate treatment of children 
with these infections at PHC centres 
and early identification of patients   
more likely to have severe illness. Inter-
vention to prevent respiratory-tract 
infections would result in a decreased 
workload at PHC centres. A better 
understanding of the causes of these 
infections, including the pathogens 
involved, is needed. Research before 
the introduction of the seven-valent 
pneumococcal vaccine in Australia 
showed that Aboriginal children are in-
fected heavily with bacterial pathogens 
such as Streptococcus pneumoniae and 
Haemophilus influenzae, and that bacte-
rial and viral coinfections are common 
in children with lower-respiratory-tract 
infections.29–31 Vaccination against bac-
terial pathogens alone will not reduce 
the burden of infections of the upper   
and lower respiratory tracts, viral vac-
cines (from respiratory syncitial virus 
and influenza to adenovirus and rhi-
novirus) are also likely to benefit these 
children.
Our study identified a previously 
undocumented burden of scabies and 
skin infections starting within the first 
few months of life. There are few lon-
gitudinal studies of scabies and many 
community-based studies are episodic 
and focus on the overall burden. While 
other studies also indicate that scabies 
is more common in young children 
than in older age groups,32,33 we believe 
this to be the first study to demonstrate 
the very early age at which scabies is 
first acquired by almost all infants in   
this setting. In addition to the indi-
vidual burden, monitoring of scabies 
and skin infections among young in-
fants may well be a useful indicator of 
scabies prevalence within the broader 
community.
The reliance on clinic data and 
population figures and the semi-subjec-
tive nature of a diagnosis of scabies are 
limitations of this study. Furthermore, 
clinic data might not accurately reflect 
the true burden of disease in a commu-
nity because not all cases will present 
to the clinic. As such, levels reported 
here are likely to be an underestimate. 
Furthermore the diagnosis of illnesses 
based solely on clinic notes is problem-
atic. Diagnoses and sufficient detail are 
often not recorded and classifications 
of diseases may thus underestimate or 
overestimate the actual disease burden. 
Data are likely to be more accurate for 
obvious health problems with objective 
signs (e.g. skin sores), but less so where 
diagnosis is more subjective, such as 
with scabies and upper-respiratory-tract 
infections. Nevertheless the skin-sore 
data reported here, and possibly the 
scabies data, are, if anything, likely to 
underestimate true levels.
Appropriate treatment of scabies 
in these communities is problematic. 
Recommended treatment of scabies in 
children ages < 2 months of age in these 
communities is with 3 days of 10% cro-
tamiton cream,34 this is less efficacious 
than 5% permethrin cream, although 
failure rates with both crotamiton and 
permethrin might be higher in children 
under 1 year of age than in older chil-
dren.35–38
Oral ivermectin has been success-
ful in community-based treatment 
programmes for scabies in Papua New 
Guinea,39 the Solomon Islands40 and 
Vanuatu,41 and has been used to treat 
millions of adults for nematode infec-
tions.42 Although there are limited data 
on the safety of ivermectin in children, 
it is being increasingly used in children 
aged > 5 years for both individual 
therapy and in community scabies pro-
grammes. Ivermectin will probably have 
an increasing role in younger children 
as safety data accumulate. Because of 
their close personal contact with adults 
and other children, young children with 
scabies and skin sores can potentially 
spread infections to large numbers of 
community members. To achieve a sus-
tainable decrease in scabies prevalence 
in communities, adequate treatment of 
these children is important.
Treating individual cases of scabies 
is time consuming, expensive and inef-
fective.43–45 A successful community-
based scabies programme has been 
described in Panama,46 and this has 
been adapted and implemented in indi-
vidual remote Aboriginal communities 
in the Northern Territory, Australia. 
These community based programmes 
involved mass treatment with 5% per-
methrin cream, community clean-up 
days, screening and education.12,43,47 
A reduction in scabies from 32.3% to 
less than 10% was seen in children in 
one community and maintained for > 2 
years, with incidence and severity of 
pyoderma also substantially decreased.12 
However, in some communities initial 
reductions were achieved, but levels 
returned towards preintervention levels 
within 1 year.43 There is high mobility 
between houses and communities in 
this region, which is likely to result in 
the reintroduction of scabies. Treating 
communities in isolation is unlikely 
to produce a sustainable decrease. The 
East Arnhem Regional Healthy Skin 
Program is a regional collaboration to 
reduce scabies, skin sores and associated 
chronic diseases. An expansion of the 
previously mentioned programmes, it 
involves six communities in the region 
and began in 2004.
Recommendations from this work 
for improved control of scabies, pyo-
derma and other high-burden infec-
tions include syndromic treatment 
protocols, community child screening 
and treatment of cases and contacts 
where appropriate and a focus on re-
gional coordinated approaches, such 
as the “healthy skin days”. In addition, 
it is crucial to continue efforts to ad-
dress the underlying causes of these Research
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extremely high rates of scabies and 
bacterial skin infections: overcrowding,   
difficulties with sanitation and continu-
ing socioeconomic disadvantage.13
The situation in these communi-
ties in remote tropical Australia is likely   
to be similar in other countries in the 
region and elsewhere where scabies re-
mains a problem.11 In conclusion, this 
study found that very young children 
are at high risk of skin infections and 
especially scabies. Further research into 
safe and effective treatments for scabies 
in this age group is needed.  ■
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Résumé
Charge de morbidité et présentation dans les dispensaires des jeunes enfants appartenant à des 
communautés aborigènes éloignées du Nord de l’Australie
Objectif Déterminer la fréquence de présentation dans les   
services de soins de santé primaire et la charge de morbidité des 
jeunes enfants de deux communautés aborigènes éloignées du 
Nord de l’Australie.
Méthodes Ont participé à l’étude les enfants nés après le 1er 
janvier 2001, résidant à cet endroit le 30 septembre 2005 et 
pour lesquels un consentement avait été obtenu. On a relevé 
dans les registres des dispensaires toutes les présentations 
d’enfants entre le 1er janvier 2002 et le 30 septembre 2005.   
Parmi les informations recueillies figuraient les motifs de la 
présentation (en cas de pathologie infectieuse), ainsi que la 
prescription d’antibiotiques et l’orientation vers un hôpital 
éventuelles.
Résultats On a recensé 7273 présentations dans un dispensaire, 
de 174 enfants de 0 à 4,75 ans, dont 55 % de garçons. La 
médiane du taux de présentation par enfant et par an était de 
16 (23 au cours de la première année de vie). Les infections des 
voies respiratoires supérieures (32 %) et les lésions cutanées 
(18 %) étaient les causes infectieuses les plus courantes de 
présentation. Les premières présentations pour une gale ou 
une lésion cutanée atteignaient un pic pour l’âge de 2 mois.   
Après 1 an, 63 et 69 % respectivement des enfants avaient été 
présentés pour une gale ou une lésion cutanée.
Conclusion En moyenne, ces enfants aborigènes étaient présentés 
deux fois par mois dans un centre de santé primaire pendant leur 
première année de vie. Ce taux élevé de fréquentation témoigne de la 
forte morbidité, de la volonté des populations aborigènes de recourir 
à ces services et de l’importante charge de travail qui pèse sur ces 
derniers. La gale et les lésions cutanées restent des problèmes de santé   
importants, représentant une charge de morbidité notable dès les 
premiers mois de la vie, comme l’atteste, pour la première fois, 
la présente étude. Les stratégies de prévention et de traitement 
appropriées doivent englober la petite enfance pour réduire   
la forte charge de morbidité due aux maladies infectieuses dans 
cette population.
Resumen
Carga de morbilidad y visitas a consultorios entre los niños pequeños en comunidades aborígenes remotas 
del norte de Australia
Objetivo Determinar la frecuencia de visitas y la carga de 
morbilidad infecciosa en los servicios de atención primaria 
(AP) entre los niños pequeños en dos comunidades aborígenes   
remotas de zonas tropicales del norte de Australia.
Métodos Se estudió a una población de niños que habían nacido 
después del 1 de enero de 2001 y residían en la zona al 30 de 
septiembre de 2005, tras obtener el consentimiento informado 
oportuno. Se examinaron los datos clínicos correspondientes a 
todas las visitas realizadas entre el 1 de enero de 2002 y el 30 
de septiembre de 2005. Entre los datos recopilados figuraban el 
motivo de la visita (si era un proceso infeccioso), la prescripción 
de antibióticos y la posible derivación a un hospital.
Resultados Se consideraron en total 7273 visitas a consultorios 
de 174 niños de 0 a 4,75 años, el 55% de los cuales eran 
varones. La tasa mediana de visitas por niño y año fue de 16 (23 
en el primer año de vida). Las infecciones de las vías respiratorias 
superiores (32%) y las infecciones cutáneas (18%) fueron las   
causas infecciosas más frecuentes de visita al consultorio. Las 
primeras visitas por sarna o heridas cutáneas presentaban un pico a 
la edad de dos meses. Al año de edad, el 63% y el 69% de los niños 
habían acudido con sarna y heridas cutáneas, respectivamente.
Conclusión Los niños aborígenes estudiados hicieron como 
promedio unas dos visitas al mes a los centros de atención 
primaria durante su primer año de vida. Esa elevada tasa refleja 
la carga de morbilidad existente, la voluntad de la población 
aborigen de usar los servicios de salud y el gran volumen de 
trabajo a que deben hacer frente esos servicios. La sarna y las 
heridas cutáneas siguen siendo problemas sanitarios importantes   
en esa población, y el estudio pone de relieve por primera vez que 
esas afecciones suponen una carga ya en los primeros meses 
de vida, de modo que, para conseguir reducir la alta morbilidad 
infecciosa en esa población, las estrategias de prevención y 
tratamiento deben abarcar el periodo neonatal.280 Bulletin of the World Health Organization | April 2008, 86 (4)
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صخلم
ايلارـتسأ لماش في ينِّـيلصلأا ناكسلل ةيئانلا تاعمتجلما في لافطلأا راغص ىدل ةيحصلا ةياعرلا تادايع ةعجارمو ضرلما ءبع
 ءبعو ،ةيلولأا ةيحصلا ةياعرلا قفارم ةعجارم راركت لىع فُّرعتلا :فدهلا
 في ينِّـيلصلأا ناكسلل  ْن ينـَّيئان  ْن ينَعمتجم في لافطلأا راغص ينب ةيدعلما ضارملأا
.ايلاترسأ لماش في ةيرادلما ةقطنلما
/نياثلا نوناك نم لولأا دعب اودلو نيذلا لافطلأا ةساردلا في جردُأ :ةقيرطلا
 برمتبس/لوليأ 30 في ةساردلا عقاوم في نونطقي اوناك نيذلا نم ،2001 رياني
 تادايعلا تلاجس تعجورو .ةساردلا لىع مهتقفاوم لىع لوصحلا متو ،2005
 برمتبس/لوليأ 30و رياني/نياثلا نوناك نم لولأا ينب اهوعجار نم عيمجل
 ًاضارمأ تناك اذإ( ةعجارلما بـبس ةعمجلما تايطعلما تنَّمضتو .2005
.تايفشتسلما لىإ ةلاحلإا تلااحو ،ةفوصولما ةيويحلا تاداضلماو ،)ةيدعم
 174 وحنل ةعجارم 7273 وحن تادايعلا تاعجارم ددع غلب :تادوجولما
 %55 وحن روكذلا لِّـثيمو ،ًاماع 4.75و 0 ينب مهرماعأ حواترـت نَّمـم ًلافط
 اهنم( ةرم 16 وحن ًايونس لفط لكل ةعجارلما لدعم طسوتم غلبو .مهنم
 يولعلا سيفنتلا زاهجلا ىوادع تناكو .)رمعلا نم لىولأا ةنسلا في ةرم 23
 يتلاو ًاعويش ىودعلا بابسأ ثركأ نم )%18( ةيدلجلا ىوادعلاو )%32(
 ،برجلا  بـبسب  تاعجارلما  لىوأ  تلصوو  .تادايعلا  ةعجارم  تعدتسا
 تغلب ،لولأا ماعلا غولب دنعو .نْنيَرهش رمع في اهتورذ لىإ دلجلا تاباهتلاو
 برجلا بـبسب ةيلولأا ةيحصلا ةياعرلا قفارم اوعجار نيذلا لافطلأا ةبسن
.لياوتلا لىع %69 وحن دلجلا تاباهتلا بـبسبو %63 وحن
 ةيحصلا ةياعرلا زكارلم ينِّـيلصلأا لافطلأا ءلاؤه تارايز تغلب :جاتنتسلاا
 اذه نإ .رمعلا نم لىولأا ةنسلا للاخ طسوتلما في  ْن ينَترايز وحن ةيلولأا
 ينِّـيلصلأا ناكسلا ةبغرو ،ضرلما ءبع لىع دهاش  ْن يَخ وهل عفترلما لدعلما
 قتاع لىع ىقللما لمعلا ءبع ةماسجو ،ةيحصلا تامدخلا نم عافتنلاا في
 لكاشم نلاِّـثيم نلاازي لا دلجلا باهتلاو ،برجلاف .ةيحصلا تامدخلا هذه
 في أدبت يتلا تلااحلا هذه ءبع ةساردلا هذه حضوتو ،ةسوملم ةيحص
 لمشت نأ يغبني َّمَـث نمو .اهقيثوت قبسي لم يتلاو ،رمعلا نم لىولأا رهشلأا
 صيلقت َةَيْنغُب ةركبلما ةلوفطلا ةرـتف ةبسانلما ةياقولاو ،ةجلاعلما تايجيتارـتسا
.ناكسلا ينب ةيدعلما ضارملأل عفترلما ءبعلاResearch
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